Trulieve Cannabis Corp. is a vertically integrated cannabis company and multi-state operator in the United States. The company cultivates, processes, and manufactures cannabis products, including flower, concentrates, and infused goods, for sale through its own retail dispensaries and wholesale distribution networks. Operations are organized into Southeast, Northeast, and Southwest regional hubs, with retail and cultivation facilities in Florida, Arizona, Pennsylvania, West Virginia, Ohio, Georgia, Maryland, Connecticut, and Colorado. Trulieve serves medical and adult-use customers, offering premium, modern, and value-tier branded products. The company utilizes various extraction techniques, including supercritical ethanol, carbon dioxide, and hydrocarbon extraction, to produce a wide variety of finished goods. It maintains in-house quality teams and testing laboratories to control product standards. Trulieve also engages in community outreach focused on veterans, seniors, and restorative justice initiatives.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Packaged Foods Homepage investors.trulieve.com
Sector Consumer Defensive IR page investors.trulieve.com
Tags
cannabis cultivation, cannabis retail, medical cannabis, adult-use cannabis, cannabis extraction, multi-state operator, branded products, wholesale distribution, Avenue, Cultivar Collection, Muse, Modern Flower, Momenta, Sweet Talk, Co2lors, Roll One, Alien Labs, Bellamy Brothers, Binske, Black Buddha, Black Tuna, Blue River, Connected, DeLisioso, Khalifa Kush, Love’s Oven, Miami Mango, Moxie, Redemption Cannabis, Seed Junky, Sunshine Cannabis
Press page —

Metrics

Valuation  
Market cap $ 1.86B
Market cap (USD) $ 1.86B
P/E -4.16
PEG —
P/BV 2.41
P/S 1.72
P/OCF 7.67
P/FCF 8.13
Dividend yield —
Turnover / mcap —
Returns  
ROE -10.2%
ROI -9.6%
ROIC 5.6%
Profit margin -10.3%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 25.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 24
Quality score -16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 1.181B 1.186B 1.129B 1.24B 938.385M 521.533M
Net profit -122.248M -160.577M -533.136M -252.727M 17.445M 62.998M
Free cash flow 228.628M 149.964M 161.456M -141.653M -263.004M -298K

Filed figures

Figure Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 308,000 8.85M 9.44M 6.7M 8.29M 10.5M
↳ YoY growth +2,774.7% +6.7% -29.0% +23.6% +26.7%
↳ 5y CAGR +102.5%
Lease liabilities (USD) — — 68.5M 203M 197M 172M 207M 196M
Cash and deposits (USD) — 91.8M 147M 231M 212M 201M 239M 256M
Intangible assets (USD) — 26.4M 90.1M 1.12B 1.01B 917M 859M 798M
Right-of-use assets (USD) — — 28.2M 126M 101M 95.9M 120M 108M
Cash flow detail
Operating cash flow (USD) — 19.1M 99.6M 12.9M 23.1M 202M 271M 273M
Purchases of property, plant and equipment (USD) — -71.8M -35.9M -276M -165M -40.4M -122M -44.2M
Purchases of intangible assets (USD) — — — -3.72M -9.21M -10.6M -25.1M -16.3M
Change in receivables (cash effect) (USD) — — 1.11M -4.9M -4.21M -1.71M 741,000 -3.72M
Change in inventories (cash effect) (USD) — -54.5M -22.5M -19.6M -83.4M 83.3M -18.7M -10.9M
Change in payables (cash effect) (USD) — 13.6M 298,000 -9.66M -819,000 1.64M 7.21M -11.3M
Interest paid (cash effect) (USD) — -7.42M -22.1M -39.1M -76.1M -81.2M -65.4M -70.3M
Income taxes paid (cash effect) (USD) — -43.7M -105M -179M -147M -52.6M 48.4M -1.46M
Share-based compensation (USD) 15M — 2.77M 9.25M 18.1M 10.6M 20.2M 20.5M
Operating cash flow before change in receivables (USD) — — 98.5M 17.8M 27.3M 204M 271M 277M
Free cash flow (OCF - PPE - intangibles) (USD) — -52.8M -298,000 -267M -151M 151M 125M 212M
Income detail
Provision for credit losses (USD) — — — 500,000 3.62M 2.75M 461,000 -1.87M
Credit cost ratio (credit losses / average receivables) (%) — — — 10.9% 39.5% 34.1% 6.2% 19.9%
Reported Aug 12, 2021 Mar 8, 2023 Mar 30, 2022 Mar 30, 2022 Mar 8, 2023 Feb 29, 2024 Feb 27, 2025 Feb 26, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Trulieve Reports Third Quarter 2026 Results Bull 5 Bear 0 Results

•Third quarter revenue of $230 million, with 64% gross margin

•Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026

•Received final DEA registrations pursuant to final order rescheduling state licensed medical marijuana to Schedule III under the Controlled Substances Act

Tallahassee, FL – November 5, 2026 – Trulieve Cannabis Corp. (NYSE: TRLV) (“Trulieve” or “the Company”), a leading and top-performing medical cannabis company in the U.S., today announced its results for the quarter ended September 30, 2026. Results are reported in accordance with U.S. Generally Accepted Accounting Principles (GAAP), unless otherwise indicated. Numbers may not sum perfectly due to rounding.

Q3 2026 Financial and Operational Highlights*

•Revenue of $230 million, with 95% of revenue from retail sales.

•Achieved gross margin of 64%, with gross profit of $148 million.

•Reported positive net income attributable to common shareholders of $1 million. Adjusted net income of $18 million* excludes non-recurring charges, asset impairments, disposals, and unconsolidated entity.

•Achieved adjusted EBITDA of $89 million*, or 39% of revenue.

TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the full repayment of an approximately $65 million mortgage notes payable secured by a cultivation site in Jefferson County, Florida, thereby reducing outstanding debt to approximately $225 million.

Trulieve logo

"We used our strong cash generation to repay this mortgage prior to its maturity date as part of our long term strategy to bolster our financial position," said Trulieve CEO Kim Rivers. "Reducing balance sheet leverage lowers our annual interest expense, improving profitability and cash flow. Given the strength of our platform, we are well positioned to fund growth initiatives in the near term including expansion in Georgia and Texas, pending regulatory approvals."

Forward-Looking StatementsThis news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from those contained in the forward-looking statements. Risks and uncertainties include, without limitation, the risks and factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR+ at www.sedarplus.ca. There can be no assurance that any forward-looking statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

About TrulieveTrulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.

Facebook: @Trulieve Instagram: @Trulieve X: @Trulieve

Investor and Media ContactChristine Hersey, Chief Corporate Affairs and Strategy Officer +1 (424) 202-0210 [email protected]

SOURCE Trulieve Cannabis Corp.

Trulieve logo

©2018 – 2026 Trulieve - All Rights Reserved.Terms & ConditionsPrivacy PolicyADA Compliance

ToolStudios

Get the latest insight from Trulieve!

Sign-up to receive special offers, promotions, and insight from Trulieve.

Close

           (opens in a new window)

TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Thursday, November 5, 2026 at 8:30 AM Eastern Time following the release of its third quarter 2026 financial results.

Trulieve logo

Chairman, Founder, and Chief Executive Officer Kim Rivers and Chief Financial Officer Jan Reese will participate on the call to review Trulieve's financial and operating results.

Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call and ask to join the Trulieve Cannabis Corp. call.

| North American toll free: 1-844-824-3830 | Passcode: | 8639220 |

| International: 1-412-542-4136 | Passcode: | 8639220 |

A live audio webcast of the conference call will be available at: Trulieve Third Quarter 2026 Results Call

An archived replay of the webcast will be available at: https://investors.trulieve.com/events

About TrulieveTrulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.

Facebook: @Trulieve Instagram: @Trulieve X: @Trulieve

Investor and Media ContactChristine Hersey, Chief Corporate Affairs and Strategy Officer +1 (424) 202-0210 [email protected]

SOURCE Trulieve Cannabis Corp.

Trulieve logo

©2018 – 2026 Trulieve - All Rights Reserved.Terms & ConditionsPrivacy PolicyADA Compliance

ToolStudios

Get the latest insight from Trulieve!

Sign-up to receive special offers, promotions, and insight from Trulieve.

Close

           (opens in a new window)

Prompts

Trulieve Cannabis Corp. (ticker TRLV), listed in United States.

Company History

Date Change Detail
— Former tickers TCNNF

ETFs Holding Trulieve Cannabis Corp.

ETF Weight in ETF Shares Market value As of
MSOS 38.76% 24,976,608 $ 251.514M Nov 17, 2026
YOLO 16.60% 455,882 $ 4.591M Nov 17, 2026
DFAS 0.00% 12,228 $ 136.342K Nov 12, 2026
DFAT 0.00% 7,593 $ 84.662K Nov 12, 2026
DFUS 0.00% 1,581 $ 17.628K Nov 12, 2026
DFAC 0.00% 3,988 $ 44.466K Nov 12, 2026
DXUV 0.00% 100 $ 1,115.00 Nov 12, 2026